These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9191886)

  • 21. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
    Carpenter PA; Pavlovic S; Tso JY; Press OW; Gooley T; Yu XZ; Anasetti C
    J Immunol; 2000 Dec; 165(11):6205-13. PubMed ID: 11086054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term in vivo depletion of functional CD4+ T lymphocytes from calves requires both thymectomy and anti-CD4 monoclonal antibody treatment.
    Valdez RA; McGuire TC; Brown WC; Davis WC; Knowles DP
    Immunology; 2001 Apr; 102(4):426-33. PubMed ID: 11328376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.
    Rowan WC; Hale G; Tite JP; Brett SJ
    Int Immunol; 1995 Jan; 7(1):69-77. PubMed ID: 7718516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
    Alegre ML; Collins AM; Pulito VL; Brosius RA; Olson WC; Zivin RA; Knowles R; Thistlethwaite JR; Jolliffe LK; Bluestone JA
    J Immunol; 1992 Jun; 148(11):3461-8. PubMed ID: 1534096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine immunoglobulin G anti-CD4 monoclonal antibodies bind to primary human monocytes and macrophages through Fc receptors as well as authentic CD4.
    Teppler H; Lee SH; Rieber EP; Gordon S
    AIDS; 1990 Jul; 4(7):627-32. PubMed ID: 2397055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
    Cobbold SP; Castejon R; Adams E; Zelenika D; Graca L; Humm S; Waldmann H
    J Immunol; 2004 May; 172(10):6003-10. PubMed ID: 15128783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective in vivo depletion of CD4(+) T lymphocytes with anti-CD4 monoclonal antibody during acute infection of calves with Anaplasma marginale.
    Valdez RA; McGuire TC; Brown WC; Davis WC; Jordan JM; Knowles DP
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):417-24. PubMed ID: 11874888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors.
    Nordström E; Möller E; Abedi-Valugerdi M
    J Autoimmun; 1998 Apr; 11(2):131-40. PubMed ID: 9650092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes.
    Morel P; Vincent C; Wijdenes J; Revillard JP
    Mol Immunol; 1993 May; 30(7):649-57. PubMed ID: 8098132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.
    Cole MS; Stellrecht KE; Shi JD; Homola M; Hsu DH; Anasetti C; Vasquez M; Tso JY
    Transplantation; 1999 Aug; 68(4):563-71. PubMed ID: 10480417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
    Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
    Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signals.
    Fournel S; Vincent C; Assossou O; Gorman SD; Robinet E; Phillips JM; Flacher M; Cordier G; Waldmann H; Revillard JP
    Transplantation; 1996 Oct; 62(8):1136-43. PubMed ID: 8900315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CD8 monoclonal antibody protects against spontaneous IgA nephropathy in ddY mice.
    Shimamine R; Shibata R; Ozono Y; Harada T; Taguchi T; Hara K; Kono S
    Nephron; 1998; 78(3):310-8. PubMed ID: 9546692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the alpha-chain of the human interleukin-2 receptor.
    Weissenhorn W; Scheuer W; Kaluza B; Schwirzke M; Reiter C; Flieger D; Lenz H; Weiss EH; Rieber EP; Riethmüller G
    Gene; 1992 Nov; 121(2):271-8. PubMed ID: 1446824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
    Ceuppens JL; Van Vaeck F
    Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.
    Bugelski PJ; Herzyk DJ; Rehm S; Harmsen AG; Gore EV; Williams DM; Maleeff BE; Badger AM; Truneh A; O'Brien SR; Macia RA; Wier PJ; Morgan DG; Hart TK
    Hum Exp Toxicol; 2000 Apr; 19(4):230-43. PubMed ID: 10918514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.